Clinicians have often pondered if cancer cells could be selectively targeted, and how payloads ranging from fluorescent dyes to oncology drugs could be accurately delivered to these cells, and then safely cleared through the kidneys. Now, researchers at Memorial Sloan Kettering Cancer Center, and Nanotechnology in the College of Engineering at Cornell University have found the answer in the form of a new class of ultra-small nanoparticles that are showing significant potential for cancer diagnosis and treatment, and positive results in pre-clinical and clinical trials.
Researchers are finding that the use of new ultra-small nanoparticles called C-dots allows improved visualization in Positron Emission Tomography (PET) scans for diagnosis and real-time image-guided intraoperative mapping of nodal metastases to aid in precise surgical excision, currently in Phase II human clinical trials.
These ultra-small particles can also serve as a precision therapeutic solution, targeting and penetrating cancer cells to deliver a range of cancer-killing drugs, with the promise of unused particles and the drugs they carry safely leaving the body through the renal system.
The architecture of the C-dot is an ultra-small silica nanoparticle with a diameter of less than 10 nanometers, first innovated at Cornell University by Ulrich Wiesner, the Spencer T. Olin Professor of Engineering. Silica, also known as silicon dioxide (SiO2), is a widely existing inorganic composition which can be found in many places, e.g. plants, cosmetics, medicine and food such as bread crust.
Multiple near infrared (near-IR) fluorescent dye molecules can be covalently encapsulated inside the silica particle, and the fluorescence brightness of these molecules is further enhanced by the rigid surrounding silica matrix. As a result, the overall fluorescence brightness of C-dots can be one order of magnitude higher than that of dyes alone, delivering new capabilities to surgeons. Meanwhile, the surface of C-dots is covalently covered with polymer chains to increase bio-compatibility. Due to the high versatility of the synthesis chemistry of C-dots, different functional ligands can be selectively attached to the end of some of the polymer chains on the C-dot surface to endow the particles with a variety of functionalities for different applications, including, but not limited to cancer targeting, radio-isotopes chelating, and small molecule drug delivery.
Importantly, the ultra-small hydrodynamic size of C-dots enable them to be efficiently cleared from the body through the renal system.
Image Credit: Elucida Oncology
News This Week
NanoApps Medical is investigating the possibility that superparamagnetic nanoparticles (SPIONs) and other classes of nanoparticles (e.g., gold coated nanoshells) might have the capacity to target cancerous tumors, metastasizing cancer cells, pathogens, etc. to deactivate/eliminate [...]
If a little humanoid robot begged you to not shut it off, would you show compassion? In an experiment designed to investigate how people treat robots when they act like humans, many participants struggled [...]
Artificial intelligence and machine learning tools have the potential to analyze large datasets and extract meaningful insights to enhance patient outcomes, an ability that is proving helpful in radiology and pathology. Images obtained by [...]
Researchers at the University of East Anglia have developed a new nanoparticle-based cancer therapy to deliver a combination therapy directly to cancer cells. The new therapy, which has been demonstrated to make prostate cancer [...]
When Joe Rubinsztain started gMed, he was admittedly young—only a few years removed from medical school— and he just didn’t understand leadership that well. “I needed to be abreast of everything and understand everything [...]
Healthcare organizations are likely to see a rapidly growing market around artificial intelligence tools for medical imaging, a new report predicts. The market for artificial intelligence (AI) tools to process and analyze medical imaging [...]
Tuberculosis, a bacterial disease which predominantly affects the lungs, isn’t all that common a sight in the United States. On average, fewer than 10,000 cases are reported each year in a country with [...]
Implantation of a stent-like flow diverter can offer one option for less invasive treatment of brain aneurysms – bulges in blood vessels – but the procedure requires frequent monitoring while the vessels heal. Now, [...]
Clinicians have often pondered if cancer cells could be selectively targeted, and how payloads ranging from fluorescent dyes to oncology drugs could be accurately delivered to these cells, and then safely cleared through the [...]
They’re not ready for human eyes yet, but one day these artificial corneas might help people see... Scientists have 3D printed the thin protective film over the eye, called the cornea, using human [...]
The UK company is the latest to join ranks of AI-focused drugmakers attracting venture capital. The researcher who invented Viagra and a colleague at Cambridge University have become the latest to join the ranks [...]
When will nanotechnology ever revolutionise medicine? These breakthroughs suggest it’s already started
After decades of promise, recent breakthroughs suggest that nanomedicine is finally living up to its potential. And we need to make sure that hospitals are ready for the revolution. Since the emergence of nanotechnology [...]
When nanoparticles are used for drug delivery, they often end up in the liver or spleen instead of the intended target. A team led by Jacob S. Brenner and Vladimir Muzykantov of the University [...]
AEROSOLS FOR GOOD. You may have sworn off aerosol sprays in the ’90s when everyone was talking about the hole in the ozone layer, but a team of researchers from MIT has found a [...]